Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

25 Mar 2019 07:00

RNS Number : 7798T
Standard Life Private Eqty Trst PLC
25 March 2019
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 31 December 2018

 

· The net asset value ("NAV") per ordinary share of Standard Life Private Equity Trust PLC ("the Company") decreased by 0.5% to 428.2 pence for the quarter ended 31 December 2018

· Realised gains and income on the unquoted portfolio during the quarter ended 31 December 2018 totalled £11.3 million (1.7% of NAV). The unrealised loss on a constant exchange rate basis was 11.4 million (1.7% of NAV). In addition, there were unrealised foreign exchange gains of £4.9 million (0.7% of NAV)

· The final quarter dividend for the financial year ending 30 September 2018 of 3.1 pence per share was paid on 25 January 2019

· 99.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2018

· NAV total return was 0.1% for the three months from 1 October 2018 to 31 December 2018

· Outstanding commitments were £385.6 million at 31 December 2018

· Resources available for investment were £95.6 million at 31 December 2018

 

For the quarter ended 31 December 2018, the Company's NAV decreased by 0.5% to 428.2 pence per share, from 430.2 pence per share at 30 September 2018. At 31 December 2018, the Company's net assets were £658.3 million (30 September 2018 - £661.4 million). NAV total return was 0.1% for the three months from 1 October 2018 to 31 December 2018.

 

The closing value of the Company's unquoted portfolio, which, included 55 private equity fund interests, was £562.1 million at 31 December 2018 (30 September 2018 - £574.7 million and 55 private equity fund interests). The total unrealised loss on the unquoted portfolio for the quarter ended 31 December 2018 was £6.5 million, comprising £11.4 million of unrealised loss on a constant exchange rate basis and £4.9 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) both fell by 11% during the quarter. The unrealised foreign exchange gains were driven by the euro and the US Dollar appreciating by 0.8% and 2.3% respectively, relative to sterling over the quarter.

 

During the quarter ended 31 December 2018, the unquoted portfolio generated £28.7 million of distributions (quarter ended 30 September 2018 - £24.4 million). The Company funded £11.4 million of drawdowns (quarter ended 30 September 2018 - £31.0 million) into the unquoted portfolio. The distributions received during the quarter generated £11.3 million of net realised gains and income. The net realised gains and income include the realised loss on written-off investments which were previously already recognised within unrealised losses. Excluding the realised loss on written-off investments, the net realised gains and income was £17.1 million. This was equivalent to a return of 2.5 times the acquisition cost of the realised investments.

 

The Company made one new fund commitment of €30.0 million to Triton V. The Company had total outstanding commitments to its 55 private equity fund interests of £385.6 million at 31 December 2018 (30 September 2018 - £369.3 million to 55 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 31 December 2018, the Company had resources available for investment of £95.6 million (30 September 2018 - resources available for investment of £86.5 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

2. Activity since 31 December 2018

 

On 25 January 2019, the Company paid the final dividend for the year ended 30 September 2018 of 3.1 pence per ordinary share. The cost of the final dividend was £4.8m. In addition, the Company declared a first quarter dividend for the year ending 30 September 2019 of 3.2 pence per share, to be paid on 26 April 2019, to shareholders on the Company's share register as at 22 March 2019. The ex-dividend date is 21 March 2019.

 

During the period from the 1 January 2019 to the 8 March 2019 the Company funded £14.2 million of drawdowns and received £11.8 million of distributions.

 

A new commitment of €35m was made to Altor V on 6 February 2019, and a new co- investment commitment of €6m was made to Mademoiselle Desserts, alongside IK Investment Partners, on 15 February 2019.

 

At 8 March 2019, the Company had resources available for investment of £90.6 million. The Company also had total outstanding commitments of £394.0 million.

 

The Company's estimated NAV at 28 February 2019 is also being announced today. It is anticipated that the Company will release its results for the six months ending 31 March 2019 on or around 19 June 2019.

 

For further information please contact:-

 

Merrick McKay at SL Capital Partners LLP (0131 245 2345)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc and Phoenix Group Holdings.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTELLFLKXFZBBQ
Date   Source Headline
16th Mar 20117:30 amRNSQuarterly Trading Statement
31st Jan 20113:54 pmRNSDirector/PDMR Shareholding
31st Jan 20113:53 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
31st Jan 201111:03 amRNSDirector/PDMR Shareholding
27th Jan 201111:03 amRNSAnnual Financial Report
26th Jan 20119:33 amRNSIssue of Equity
25th Jan 20114:08 pmRNSResult of AGM
25th Jan 20111:00 pmRNSInterim Management Statement
17th Jan 201111:28 amRNSDirector/PDMR Shareholding
6th Jan 20112:05 pmRNSCalculation of Script Dividend Reference Price
6th Jan 201111:28 amRNSQuarterly Disclosure
21st Dec 201011:07 amRNSDoc re. Annual Report
20th Dec 20104:26 pmRNSAnnual Information Update
8th Dec 20104:02 pmRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSPreliminary Results for year to 30/09/10
2nd Dec 20102:30 pmRNSDirectorate Change
30th Nov 20107:00 amRNSRefinancing of debt facility
17th Nov 20109:20 amRNSDirector Declaration
4th Oct 20102:45 pmRNSQuarterly Disclosure
30th Sep 20105:30 pmRNSTotal Voting Rights
28th Sep 201010:46 amRNSApplication for Listing
22nd Sep 20107:00 amRNSInvestment update for quarter to 30 June 2010
10th Aug 201012:49 pmRNSInterim Management Statement
2nd Jun 201012:36 pmRNSHolding(s) in Company
28th May 20107:00 amRNSHalf Yearly Report
9th Apr 201012:46 pmRNSHolding(s) in Company
17th Mar 20107:00 amRNSTrading Statement
9th Feb 201011:40 amRNSDirector/PDMR Shareholding
8th Feb 201010:19 amRNSDirector/PDMR Shareholding
2nd Feb 20103:02 pmRNSDirector/PDMR Shareholding
1st Feb 201011:14 amRNSDirector/PDMR Shareholding
1st Feb 201011:12 amRNSDirector/PDMR Shareholding
1st Feb 201011:10 amRNSDirector/PDMR Shareholding
1st Feb 201011:06 amRNSTotal Voting Rights
27th Jan 20103:39 pmRNSResult of AGM
27th Jan 201012:13 pmRNSInterim Management Statement
27th Jan 201010:00 amRNSApplication for Listing
20th Jan 20109:47 amRNSHolding(s) in Company
14th Jan 201011:30 amRNSAnnual Financial Report
12th Jan 201010:39 amRNSAnnual Information Update
7th Jan 20104:41 pmRNSCalculation of scrip dividend reference price
5th Jan 201012:46 pmRNSQuarterly Disclosure
23rd Dec 200910:57 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20092:25 pmRNSDoc re. Annual Report and Circular
3rd Dec 200912:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSPreliminary results for year to 30/9/09
18th Sep 20097:00 amRNSThird Quarter Trading Statement
29th Jul 20097:30 amRNSInterim Management Statement
8th Jul 20092:23 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.